Replies to post #13067 on Mast Therapeutics, Inc. (MSTX)

[kld2]

Blink, curious: what do you expect them to say on September 3rd that might change the mind of the marketplace? I agree: it's severely undervalued. Thanks.

[BooDog]

I was impressed. Very much looking forward to the conference in October and the presentation. I likely won't be there though this team is moving forward very nicely. Very strong study design and goals.

"Why have successful tests and not share results? " Because EPIC is blinded, NOBODY has results to share yet.

EPIC-E is open label, unblinded study: https://clinicaltrials.gov/ct2/show/NCT02449616?term=mast+therapeutics&rank=2

The mom of that child from Sickle Cell Unite that shared the "No pain" after being on MST-118 after 24hrs must of been enrolled in EPIC-E, or she wouldn't of known what he was dosed on. EPIC-E started in May and is enrolling 388, we may start seeing a lot more of these patient experiences being shared.

"at little pr goes a long way."
Brian is addressing.

"we are being severely undervalued by the marketplace. Consequently, on September 3rd, we will be presenting at Fourth Annual Sickle Cell Drug Development Conference and on October 7th, we plan to host our first-ever Mast R&D event. Botsh of these events will be held in New York City and every investor and analyst in our database will be invited to attend. We also will webcast our R&D event on October for those investors who cannot attend in person."

BTW, If anyone thinks Brian is not a hard worker, I'd think again, this man routinely answers my emails at 5:30am. From the tone of the EPS CC, you can surmise how focused he is on presenting an amazing and thorough NDA package to the FDA. The typical NDA has thousands and thousands of pages and could fill up the back of a truck. All that you heard on the CC is being completed due to MANY hours of hard work being put in by Brian and his team.

BTW, if you can ever get your hands on Mike Higgin's, April, 34 pg report on Mast, I would, just a FANTASTIC read. Mike is probably the most knowledgeable analyst on SCD out there.

Thanks! Will Do!

[pray]

My point was if successful promote it. If further tests are needed then be patient until results are conclusive.

If something is just mentioned to bring attention, most of the time strategy backfires and firm is accused of simply "pumping" investors.

In this case, further tests could not take that long, but would go a long way in bringing other investors in the fold, credibility, as well as increasing value of stock.

I did appreciate the post and "thanks" for the update.